Hashimoto Disease
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
335
|
131
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Autoimmune thyroiditis
|
disease |
Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
161
|
76
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
360
|
194
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
1991 |
1991 |
Mild cognitive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
430
|
96
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Congenital infectious disease
|
group |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Infections
|
Disease or Syndrome
|
29
|
7
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Oligospermia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
217
|
72
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Liver neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1424
|
7
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Azoospermia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
254
|
70
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Fanconi Anemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
394
|
173
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Epidermodysplasia Verruciformis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
64
|
9
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Rabies (disorder)
|
disease |
Infections
|
Disease or Syndrome
|
123
|
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Retinoblastoma
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
853
|
193
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |